Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Nexstim Navigated Brain Therapy (NBT) System 2

K-Number: K171902 · 2017-11-10

ApplicantNexstim Plc
Decision Date2017-11-10
Product CodeOBP
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

Nexstim Navigated Brain Therapy (NBT) System 2 is a medical device manufactured by Nexstim Plc. It received FDA 510(k) clearance on 2017-11-10 under approval number K171902. The device is classified under product code OBP. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Nexstim Navigated Brain Therapy (NBT) System 2?

Nexstim Navigated Brain Therapy (NBT) System 2 is a medical device that received FDA 510(k) clearance on 2017-11-10. It is manufactured by Nexstim Plc. The 510(k) number is K171902.

When was Nexstim Navigated Brain Therapy (NBT) System 2 approved by the FDA?

Nexstim Navigated Brain Therapy (NBT) System 2 received FDA 510(k) clearance on 2017-11-10, under approval number K171902.

What company makes Nexstim Navigated Brain Therapy (NBT) System 2?

Nexstim Navigated Brain Therapy (NBT) System 2 is manufactured by Nexstim Plc.

What is the FDA product code for Nexstim Navigated Brain Therapy (NBT) System 2?

The FDA product code for Nexstim Navigated Brain Therapy (NBT) System 2 is OBP.

Related Clinical Trials

NCT01143558 Searching for Persistence of Infection in Lyme Disease COMPLETED NCT06727942 Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes RECRUITING NCT06011187 Assisted Fluid Management (AFM) System and Postoperative Outcome After High-risk Abdominal Surgery COMPLETED NCT05016219 Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients RECRUITING NCT03280862 DANISH-CRT - Does Electric Targeted LV Lead Positioning Improve Outcome in Patients With Heart Failure and Prolonged QRS COMPLETED NCT05701917 DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis RECRUITING

Related PubMed Literature

PMID: 41966529 Comparison of the AccuPower HIV-1 Quant Kit and Aptima HIV-1 Quant Dx Assay for quantification of HIV-1 plasma viral load. Diagnostic microbiology and infectious disease (2026) PMID: 41612341 Brain-computer interface commercialization. Journal of neuroengineering and rehabilitation (2026) PMID: 40942702 Digital Cardiovascular Twins, AI Agents, and Sensor Data: A Narrative Review from System Architecture to Proactive Heart Health. Sensors (Basel, Switzerland) (2025) PMID: 40624966 Peptide-Enhanced Bioactive Hydrogel Combined with Photodynamic-Phage Synergistic Antibacterial Therapy System Accelerates Infected Wound Healing. Advanced healthcare materials (2025)

Other Devices by Nexstim Plc

K182700Nexstim Navigated Brain Therapy (NBT) System 2

Related Devices (Code: OBP)

K160309Neurosoft TMSTeleemg, LLC K161519NeuroStar TMS Therapy SystemNeuronetics, Inc. K160703NeuroStar TMS Therapy SystemNeuronetics, Inc. K173441Neurosoft TMS (also CloudTMS)Teleemg, LLC K172667MagVita TMS Therapy w/MagPro R20Tonica Elektronik A/S K171051HORIZON Therapy SystemMagstim Company, Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑